| Literature DB >> 31086219 |
Esteban M Cordero1,2, Cristian Cortez1,2, Nobuko Yoshida1, José Franco da Silveira3.
Abstract
<span class="Species">Trypanosoma cruzi, the causative agent of <span class="Disease">Chagas disease, has a dense coat of GPI-anchored virulence factors. T. cruzi GPI-anchored adhesin GP82 is encoded by a repertoire of transcripts containing several in-frame initiation codons located up-stream from that adjacent to the predicted signal peptide (SP). Transfection of T. cruzi epimastigotes with constructs encoding GP82 starting at the SP or from the farthest up-stream methionine confirmed protein expression on the parasite cell surface, comparable to the native GP82. Proteins were fully functional, inducing parasite adhesion to HeLa cells and lysosome mobilization, events required for parasite invasion. Transgenic and native GP82 proteins showed indistinguishable electrophoretic mobility, suggesting similar processing of the SP. Deletion of SP generated a ~72 kDa protein devoid of N-linked oligosaccharides allowing irrefutable identification of GP82 precursor. SP transposition to an internal region of GP82 rendered the signal unrecognizable by the signal peptidase and incapable to direct the nascent protein for ER-membrane association. Altogether our data strongly suggests that GP82 SP fails to function as transmembrane domain and its recognition by the signal peptidase shows strict dependence on the signal localization at protein N-terminus. This report presents the first experimental characterization of the full-length GP82 and its signal peptide.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31086219 PMCID: PMC6513831 DOI: 10.1038/s41598-019-43743-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Methionines up-stream from signal peptide in representative members of T. cruzi trans-sialidase (TS) superfamily.
| GenBank Accession | Source | Strain/clone | Kozak consensus* | SplicedLeader (SL)** | Protein ID | In-frame Methionines*** | Distance (aa)**** |
|---|---|---|---|---|---|---|---|
| EF154827 | cDNA | G | Yes | Yes | GP82 | 2 | 38 |
| KJ189371 | cDNA | G | Yes | Yes | GP82 | 2 | 38 |
| KJ189375 | cDNA | G | Yes | Yes | GP82 | 2 | 38 |
| KJ189377 | cDNA | G | Yes | Yes | GP82 | 2 | 38 |
| KJ189381 | cDNA | G | Yes | No | GP82 | 2 | 38 |
| KY073275 | cDNA | G | Yes | Yes | GP82 | 2 | 38 |
| XM_806590 | gDNA | CLB | Yes | No | GP82 | 2 | 38 |
| XM_810099 | gDNA | CLB | Yes | No | GP82 | 2 | 38 |
| XM_810104 | gDNA | CLB | Yes | No | GP82 | 2 | 38 |
| XM_806594 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_815090 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_801751 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_811439 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_813769 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_800440 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_804566 | gDNA | CLB | Yes | No | GP82 | 1 | 39 |
| XM_807453 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_816676 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_802018 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_799595 | gDNA | CLB | Yes | No | GP82 | 1 | 38 |
| XM_805521 | gDNA | CLB | Yes | No | GP82 | 1 | 30 |
| XM_799474 | gDNA | CLB | Yes | No | GP82 | 1 | 20 |
| KR608067 | cDNA | G | Yes | Yes | GP82 | 1 | 38 |
| EF154828 | cDNAΨ | G | Yes | No | GP82 | 1 | 38 |
| EF154829 | cDNA | G | Yes | Yes | GP82 | 0 | 0 |
| KJ189380 | cDNA | G | Yes | No | GP82 | 0 | 0 |
| XM_806823 | gDNA | CLB | Yes | No | GP82 | 0 | 0 |
| AF426132 | cDNA | G | Yes | Yes | GP90 | 1 | 38 |
| KY073276 | cDNA | G | Yes | Yes | GP90 | 1 | 38 |
| AF051696 | cDNA | CL | Yes | Yes | P85.2 (GP85) | 2 | 38 |
| XM_808586 | gDNA | CLB | Yes | No | Tc85-11 (GP85) | 1 | 38 |
| M58466 | cDNA | Peru | Yes | Yes | TSA-1 (GP85) | 1 | 37 |
| AF051695 | cDNA | CL | Yes | Yes | P85.1 (GP85) | 1 | 38 |
| CF889573 | cDNA | CLB | Yes | Yes | EST (GP85) | 1 | 38 |
| EF579921 | cDNA | Tulahuen | Yes | No | ASP-2 | 2 | 38 |
| AY186573 | cDNA | Y | Yes | Yes | ASP-2 | 1 | 38 |
| U77951 | cDNA | Brazil | Yes | Yes | ASP-2 | 1 | 38 |
| AY186574 | cDNA | Y | Yes | No | ASP-2 | 1 | 38 |
| AY186574 | cDNA | Y | Yes | No | ASP-2 | 1 | 38 |
| EF583446 | cDNAΨ | Dm28c | Yes | No | ASP-2 | 1 | 38 |
| EF579922 | cDNA | G | Yes | No | ASP-2 | 1 | 38 |
| GU445326 | cDNA | Tulahuen | Yes | No | ASP-2 | 1 | 38 |
| AY513728 | cDNA | unknown | Yes | Yes | TS Trypo ligand | 1 | 38 |
| AY298908 | gDNA | CLB | Yes | No | c71 surf protein | 1 | 38 |
| X70947 | cDNA | CL | Yes | Yes | FL-160 | 1 | 3 |
| X70948 | gDNA | CL | Yes | No | FL-160-2 | 1 | 38 |
| U59297 | cDNA | Y | Yes | Yes | CRP-10 | 2 | 38 |
| U01098 | cDNA | Y | Yes | Yes | TS epi | 0 | 0 |
| X57235 | gDNA | CAI | Yes | No | SAPA | 0 | 0 |
| AB188100 | gDNA | Y | Yes | No | TS-193 | 0 | 0 |
| D50685 | gDNA | Y | Yes | No | TCTS-154 | 0 | 0 |
*Kozak consensus sequence [gccrccATGg; lower case r denotes a purine (adenine or guanine)], presence of predicted translation initiation site adjacent to the signal peptide, as determined by NetStart 1.0 Prediction Server.
**Spliced leader (SL), presence of a common 35-nucleotide sequence (SL) found at 5′-terminal part to the 5′ end of all trypanosome mRNAs.
***In-frame methionines. The numbers indicate the quantity of in-frame start codons (ATG) located up-stream from the one which lies adjacent to the signal peptide (SP). Internal SP sequences (after the first or second in-frame ATG) are predicted to be signal anchor sequences by SignalP 3.0 Server.
****Distance in amino acids (aa) from the furthest methionine up-stream from the one located adjacent to the signal peptide.
Ψ Pseudogene.
Figure 1Schematic representation of GP82 constructs. (A) WebLogo representation of multiple sequence alignment (Clustal Omega) of uncharacterized 38 amino acids region from representative members of trans-sialidase family (from Table 1) indicating the relative frequency of amino acids at given position (height). (B) Illustrative representation of protein ABR19835 deduced from the cDNA 5.4G6 (GenBank EF154827) used as template to create the constructs 1st, 2nd, M9/39L, ΔSP and tSP. The N(1–6) depicted above the template protein, indicates putative N-glycosylation sites conserved throughout the constructs. In-frame methionines are indicated by the capital M letter (methionine at position 9 is not depicted). Capital L letter denotes the methionine to leucine substitution (M→L) introduced by site-directed mutagenesis (leucine at position 9 is not depicted) The green box denotes a 38 amino acids uncharacterized region between the 1st and 2nd constructs. The predicted SP is represented as a red box. The blue hexagon indicates the c-myc epitope introduced by PCR. P3, p4 and p8 denote the 3F6 monoclonal antibody epitope (p3), and the GP82 cell-binding sites (p4 and p8) involved in the interaction with the host-cell receptor. The black box symbolizes the GPI-anchor addition C-terminal signal where the ω is the GPI-anchor acceptor amino acid. (C) Alignment of SP of GP82 proteins derived from cDNA sequences (from Table 1) compared with c-myc tagged ABR19835 protein. Only the amino acids residues that differ from ABR19835 protein are identified, identical residues are depicted as dots. Protein accession numbers are indicated on the left. The green arrowhead denotes the predicted cleavage site by signal peptidase, between positions 27 and 28. The c-myc epitope (EQKLISEEDL) insertion site is indicated inside a blue box. Brackets labelled as n, h and c, denote the regions that compose the tripartite structure of GP82 signal peptide. EF154828 correspond to a GP82 pseudogene.
Figure 2Expression of GP82 in transfected T. cruzi epimastigotes. (A) Three micrograms of proteins from total extracts of transfected epimastigotes were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and incubated with mAb 9E10 (anti-c-myc), mAb 3F6 (anti-GP82) or anti-tubulin monoclonal antibodies. Samples were washed and incubated with peroxidase conjugated antibodies and the immunocomplexes developed by chemiluminescence. Void: transfected epimastigotes carrying the empty pTEX vector; 1st: transfected parasites carrying the pTEX-1st construct; 2nd: epimastigotes transfected with pTEX-2nd construct; M9/39L: epimastigotes transfected with pTEX-M9/39L construct. MT: wild-type metacyclic trypomastigotes from clone Dm28c or G strain. The vertical black line inside the panels denotes the boundary between lanes from the same developed membrane that were non-adjacent in the gel. Protein molecular weight standards (kDa) are indicated on the left. (B) Endoglycosidase H digestion of GPI-anchored enriched-protein extracts from transfected T. cruzi epimastigotes. GPI-enriched samples from transfected epimastigotes (5 × 105 parasite/equivalents) and MTs (1 × 105 parasite/equivalents) were treated (+) or mock treated (−) with 750 U of endoglycosidase H (Endo H) at 37 °C for 3 h. Samples were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and incubated with anti-c-myc (upper panel) or anti-GP82 (lower panel) monoclonal antibodies. Immunocomplexes were developed as described in (A). Void: epimastigotes transfected with empty pTEX plasmid; 1st: transfected parasites carrying the pTEX-1st construct; 2nd: epimastigotes transfected with pTEX-2nd construct; M9/39L: transfected parasites carrying pTEX-M9/39L construct; MT: wild-type metacyclic trypomastigotes from clone Dm28c (1 × 105 equivalent). Protein molecular weight standards (kDa) are indicated on the left. Full-length immunoblots are presented in Supplementary Fig. S5.
Figure 3(A) SP alterations in GP82 influence its electrophoretic mobility. Total protein extracts from transfected epimastigotes (6 × 106) were resolved on 10% SDS-PAGE, transferred to nitrocellulose membranes and incubated with 9E10 (anti-c-myc), 3F6 (anti-GP82) or anti-tubulin monoclonal antibodies. Void: epimastigotes transfected with empty pTEX plasmid; 2nd: transfected parasites carrying the pTEX-2nd construct; ΔSP: epimastigotes transfected with the pTEX-ΔSP construct (without SP); tSP: transfected parasites carrying the pTEX-tSP construct (transposed SP). Protein molecular weight standards (kDa) are indicated on the left. (B) Modifications in the SP impacts GP82 glycosylation. Total protein extracts from transfected epimastigotes (6 × 106) were treated (+) or mock treated (−) with 500 U of endoglycosidase H (Endo H) at 37 °C for 3 h. Samples were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and incubated with anti-c-myc (upper panel) or anti-GP82 (middle panel) monoclonal antibodies. Void: epimastigotes transfected with empty pTEX plasmid; 2nd: transfected parasites carrying the pTEX-2nd construct; ΔSP: epimastigotes transfected with pTEX-ΔSP construct (without SP); tSP: transfected parasites carrying the pTEX-tSP construct (transposed SP). Protein molecular weight standards (kDa) are indicated on the left. Full-length immunoblots are presented in Supplementary Fig. S6.
Figure 4Immunofluorescence of transfected T. cruzi epimastigotes. (A) Live parasites were washed thrice with cold PBS and incubated with mAb 3F6 (anti-GP82) for 30 min on ice. Parasites were washed and incubated with 2 µg/mL Alexa Fluor 488 conjugated anti-mouse IgG antibody containing 200 nM DAPI. Samples were mounted using ProLong Gold antifade media and analysed on Olympus BX51 epifluorescence microscope. Void: epimastigotes transfected with empty pTEX plasmid; 1st: transfected parasites carrying the pTEX-1st construct; 2nd: epimastigotes transfected pTEX-2nd construct; M9/39L: transfected parasites carrying the pTEX-M9/39L construct; Control: metacyclic trypomastigotes from stationary phase cultures. (B) Fixed parasites were treated with methanol, blocked and incubated with mAb 9E10 (anti-c-myc) for 30 min on ice and processed as described above. Void: epimastigotes transfected with empty pTEX plasmid; 1st: transfected parasites carrying the pTEX-1st construct; 2nd: epimastigotes transfected pTEX-2nd construct; M9/39L: transfected parasites carrying the pTEX-M9/39L construct; Control: metacyclic trypomastigotes from stationary phase cultures. Bar: 3 μm. (C) Flow cytometry analysis of live transfected populations incubated with mAb 3F6. Live transfected epimastigotes and wild-type MT were washed and incubated with mAb 3F6 as described above. After final wash, samples were resuspended in PBS and their fluorescence levels analysed by flow cytometry on a BD Accuri C6 Flow Cytometer acquiring 104 events.
Figure 5T. cruzi epimastigotes expressing GP82 bind to HeLa cells and induce lysosome mobilization. (A) HeLa cells seeded on glass coverslips were incubated with transfected parasites at MOI 20:1 for 1 h at 37 °C in 24-wells plates. Wells were washed with PBS to remove unbound parasites and were fixed with 4% PFA, permeabilized with 0.1% saponin (PGN-saponin) and incubated for 1 h with mouse mAb 3F6 and rabbit mAb anti-human Lamp1 diluted in PGN-saponin. Coverslips were washed and incubated for 1 h with 2 µg/mL of anti-mouse IgG conjugated to Alexa Fluor 488 and anti-rabbit IgG conjugated to Alexa Fluor 568 containing 1 µg/mL DAPI. Samples, mounted on microscopic slides using Prolong Gold, were analysed on Leica TCS SP8 Confocal Laser Scanning Platform using Leica Application suite (LAS) and Imaris (Bitplane) software packages. Lysosome detection was performed as described elsewhere[47] None: cells incubated in culture media devoid of parasites; MT: wild-type metacyclic trypomastigotes; Void: epimastigotes transfected with empty pTEX plasmid; 1st: transfected parasites carrying the pTEX-1st construct; 2nd: epimastigotes transfected pTEX-2nd construct; M9/39L: transfected parasites carrying the pTEX-M9/39L construct. White arrowheads: perinuclear lysosomes. Yellow arrowheads: lysosome scattering induced by transfected parasites. Bar: 10 μm. (B) Epimastigotes expressing GP82 were incubated with HeLa cells at MOI 20:1 for 1 h at 37 °C in 24-wells plates containing DMEM medium. After washings with PBS to remove unbound parasites and fixation in Bouin solution followed by Giemsa staining, the coverslips were mounted onto microscopic slides and the number of cell-adherent parasites recorded by microscopy. The results correspond to the mean ± SD of parasites in 300 cells counted in triplicate (* p < 0.05). (C) Quantification of lysosome mobilization/scattering from panel A analysed by lysosome counting algorithm. Bars correspond to triplicates indicating mean ± SD of 10 different microscopic fields (≥300 cells) observed with a 63× objective (* p < 0.05).